首页> 外文期刊>Analytical chemistry >In Situ Microarray Fabrication and Analysis Using a Microfluidic Flow Cell Array Integrated with Surface Plasmon Resonance Microscopy
【24h】

In Situ Microarray Fabrication and Analysis Using a Microfluidic Flow Cell Array Integrated with Surface Plasmon Resonance Microscopy

机译:使用与表面等离子体共振显微镜相结合的微流控细胞阵列原位微阵列制作和分析。

获取原文
获取原文并翻译 | 示例
       

摘要

Surface Plasmon Resonance Microscopy (SPRM) is a promising label-free analytical tool for the real-time study of biomolecule interactions in a microarray format. However, flow cell design and microarray fabrication have hindered throughput and limited applications of SPRM. Here we report the integration of a microfluidic flow cell array (MFCA) with SPRM enabling in situ microarray fabrication and multichannel analysis of biomolecule probe-target interactions. We demonstrate the use of the MFCA for delivery of sample solutions with continuous flow in 24 channels in parallel for rapid microarray creation and binding analysis while using SPRM for real-time monitoring of these processes. Label-free measurement of antibody-antibody interactions demonstrates the capabilities of the integrated MFCA-SPRM system and establishes the first steps of the development of a high-throughput, label-free immunogenicity assay. After in situ probe antibody immobilization, target antibody binding was monitored in real time in 24 channels simultaneously. The limit of detection for this particular antibody pair is 80 ng/mL which is approx6 times lower than the industry recommended immunogenicity assay detection limit. The integrated MFCA-SPRM system is a powerful and versatile combination for a range of array-based analyses, including biomarker screening and drug discovery.
机译:表面等离子体共振显微镜(SPRM)是一种有前途的无标记分析工具,用于实时研究微阵列格式中的生物分子相互作用。但是,流通池设计和微阵列制造阻碍了SPRM的通量和应用范围。在这里,我们报告与SPRM的微流控细胞阵列(MFCA)的集成,使原位微阵列制造和生物分子探针-靶标相互作用的多通道分析成为可能。我们展示了使用MFCA在24个平行通道中连续流动地提供样品溶液的功能,可快速创建芯片并进行结合分析,同时使用SPRM实时监控这些过程。抗体-抗体相互作用的无标记测量证明了集成的MFCA-SPRM系统的功能,并确立了开发高通量,无标记免疫原性测定的第一步。原位探针抗体固定后,同时在24个通道中实时监测目标抗体的结合。此特定抗体对的检出限为80 ng / mL,比行业推荐的免疫原性检测检出限低约6倍。集成的MFCA-SPRM系统是功能强大且用途广泛的组合,可用于一系列基于阵列的分析,包括生物标志物筛选和药物发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号